Trial Profile
A Single Center Dose Ranging Pilot Study of (+)-Epicatechin in Non-ambulatory Adolescents With Duchenne Muscular Dystrophy and Pre-symptomatic Cardiac Dysfunction
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 29 Dec 2021
Price :
$35
*
At a glance
- Drugs Epicatechin (Primary)
- Indications Duchenne muscular dystrophy
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 15 Jan 2019 Status changed from recruiting to completed.
- 06 Jun 2018 Planned End Date changed from 1 May 2017 to 1 Aug 2018.
- 06 Jun 2018 Planned primary completion date changed from 1 Apr 2017 to 1 Aug 2018.